BIZZARI JEAN-PIERRE (CIK 1630914) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy APRE (3,135 shares), Buy ADCT (45,000 shares), Sell ADCT (12,600 shares), Sell ADCT (12,600 shares), Buy APRE (1,045 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 3,135 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Buy | 45,000 | $0 |
| 2026-06-03 | ADC Therapeutics SA (ADCT) | Director | Sell | 12,600 | $38,808 |
| 2025-06-17 | ADC Therapeutics SA (ADCT) | Director | Sell | 12,600 | $45,108 |
| 2025-06-09 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 1,045 | $0 |
| 2025-06-05 | ADC Therapeutics SA (ADCT) | Director | Buy | 40,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17